{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:01:25Z","timestamp":1785765685684,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008967","name":"Philipps-Universit\u00e4t Marburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008967","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with limited therapeutic options, driven in part by its immunosuppressive tumor microenvironment (TME). Tumor-associated macrophages (TAMs) and neutrophils (TANs) contribute to tumor progression and immune evasion. A Disintegrin and Metalloproteinase 8 (ADAM8), a zinc-dependent protease, is strongly upregulated in PDAC and correlates with poor clinical outcomes, suggesting a regulatory role in tumor progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Wild-type (WT) and Adam8 knockout (A8KO) PDAC cell lines were generated using the CRISPR-Cas9 technique, and PDAC mouse models with or without Adam8 expression were established to investigate the role of ADAM8 in tumor and immune cells. In vitro assays, including Western blotting, qPCR, migration and invasion assays, proliferation assays, ELISA, cytokine and proteome analyses, as well as co-culture experiments with PDAC cells and either macrophages or neutrophils, were employed to assess the effects of ADAM8 on tumor\u2013immune cell crosstalk. In parallel, in vivo WT and A8KO KPC models were generated, genotyped, and monitored to evaluate the impact of ADAM8 on survival, tumor growth, and immune cell recruitment within the PDAC TME.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ADAM8 deletion reduced tumor cell proliferation and migration, associated with reduced activation of FAK\/Src\/STAT3 signaling and altered secretion of cytokines including GM-CSF, M-CSF, ICAM-1, and TNF-\u03b1. Co-culture assays demonstrated that ADAM8 enhanced reciprocal signaling between tumor cells and TAMs\/TANs, promoting pro-oncogenic activation. Migration assays and in vivo analyses revealed that ADAM8 facilitated recruitment of macrophages and neutrophils in PDAC TME, while\n                      <jats:italic>Adam8<\/jats:italic>\n                      KO tumors exhibited reduced immune infiltration and altered macrophage polarization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that ADAM8 promotes PDAC aggressiveness by enhancing tumor cell proliferation and migration, activating FAK\/Src\/STAT3 signaling, and driving macrophage and neutrophil recruitment through cytokine regulation. By orchestrating both tumor-intrinsic pathways and tumor\u2013immune interactions, ADAM8 emerges as a key determinant of PDAC progression and a systemic target for therapeutic intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13402-026-01266-7","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:04:48Z","timestamp":1785762288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment"],"prefix":"10.1007","volume":"49","author":[{"given":"Kimia","family":"Zandieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-7987","authenticated-orcid":false,"given":"Lena","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Nagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"diFazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef K.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1344-9117","authenticated-orcid":false,"given":"Uta-Maria","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Meixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9702-8581","authenticated-orcid":false,"given":"Daniela","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4312-1377","authenticated-orcid":false,"given":"Corinna","family":"Keber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-9410","authenticated-orcid":false,"given":"Christopher","family":"Nimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2773-3357","authenticated-orcid":false,"given":"J\u00f6rg W.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"2","key":"1266_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"L.D. Wood","year":"2022","unstructured":"L.D. Wood, M.I. Canto, E.M. Jaffee, D.M. Simeone, Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology 163(2), 386\u2013402.e1 (2022, Aug 1). https:\/\/doi.org\/10.1053\/j.gastro.2022.03.056","journal-title":"Gastroenterology"},{"issue":"6","key":"1266_CR2","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s12551-018-0466-8","volume":"10","author":"V. Papalazarou","year":"2018","unstructured":"V. Papalazarou, M. Salmeron-Sanchez, L.M. Machesky, Tissue engineering the cancer microenvironment\u2014challenges and opportunities. Biophys. Rev. 10(6), 1695\u20131711 (2018, Nov 8). https:\/\/doi.org\/10.1007\/s12551-018-0466-8","journal-title":"Biophys Rev."},{"issue":"1","key":"1266_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"M.H. Sherman","year":"2023","unstructured":"M.H. Sherman, G.L. Beatty, Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu. Rev. Pathol. Mech. Dis. 18(1), 123\u2013148 (2023, Jan 24). https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031621-024600","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"1","key":"1266_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-019-1117-9","volume":"18","author":"X. Liu","year":"2019","unstructured":"X. Liu, J. Xu, B. Zhang, J. Liu, C. Liang, Q. Meng, J. Hua, X. Yu, S. Shi, The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Mol. Cancer. 18(1), 184 (2019, Dec 13). https:\/\/doi.org\/10.1186\/s12943-019-1117-9","journal-title":"Mol Cancer"},{"issue":"2","key":"1266_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.coi.2013.01.006","volume":"25","author":"R.H. Vonderheide","year":"2013","unstructured":"R.H. Vonderheide, L.J. Bayne, Inflammatory networks and immune surveillance of pancreatic carcinoma. Curr. Opin. Immunol. 25(2), 200\u2013205 (2013, Apr 1). https:\/\/doi.org\/10.1016\/j.coi.2013.01.006","journal-title":"Curr Opin Immunol."},{"issue":"1","key":"1266_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s44272-023-00005-5","volume":"2","author":"T. Zhu","year":"2023","unstructured":"T. Zhu, X. Wu, Y. Liao, Y. Yan, M. Yu, L. Wang, Q. Xia, The role of innate immune cells as modulators of the tumor microenvironment in the metastasis and treatment of pancreatic cancer. CCB 2(1), 2 (2023, Dec 6). https:\/\/doi.org\/10.1007\/s44272-023-00005-5","journal-title":"CCB"},{"issue":"12","key":"1266_CR7","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3390\/biomedicines10123215","volume":"10","author":"S.S.W. Ng","year":"2022","unstructured":"S.S.W. Ng, L.A. Dawson, Inflammatory cytokines and radiotherapy in pancreatic ductal adenocarcinoma. Biomedicines 10(12), 3215 (2022, Dec 12). https:\/\/doi.org\/10.3390\/biomedicines10123215","journal-title":"Biomedicines"},{"key":"1266_CR8","doi-asserted-by":"publisher","first-page":"1358750","DOI":"10.3389\/fonc.2024.1358750","volume":"14","author":"L. Yi","year":"2024","unstructured":"L. Yi, Y. Gai, Z. Chen, K. Tian, P. Liu, H. Liang, X. Xu, Q. Peng, X. Luo, Macrophage colony-stimulating factor and its role in the tumor microenvironment: novel therapeutic avenues and mechanistic insights. Front. Oncol. 14, 1358750 (2024, Apr 4). https:\/\/doi.org\/10.3389\/fonc.2024.1358750","journal-title":"Front. Oncol."},{"issue":"6","key":"1266_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"L.J. Bayne","year":"2012","unstructured":"L.J. Bayne, G.L. Beatty, N. Jhala, C.E. Clark, A.D. Rhim, B.Z. Stanger, R. Vonderheide, Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer. Cell. 21(6), 822\u2013835 (2012, Jun 12). https:\/\/doi.org\/10.1016\/j.ccr.2012.04.025","journal-title":"Cancer Cell."},{"issue":"5","key":"1266_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1582-4934.2007.00082.x","volume":"11","author":"N. Valkovskaya","year":"2007","unstructured":"N. Valkovskaya, H. Kayed, K. Felix, D. Hartmann, N.A. Giese, S.P. Osinsky, H. Friess, J. Kleeff, ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer. J.Cellular Mol. Medi. 11(5), 1162\u20131174 (2007, Sep). https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00082.x","journal-title":"J Cellular Mol Medi"},{"issue":"50","key":"1266_CR11","doi-asserted-by":"publisher","first-page":"48210","DOI":"10.1074\/jbc.M203355200","volume":"277","author":"U. Schlomann","year":"2002","unstructured":"U. Schlomann, D. Wildeboer, A. Webster, O. Antropova, D. Zeuschner, C.G. Knight, A.J.P. Docherty, M. Lambert, L. Skelton, H. Jockusch, J.W. Bartsch, The metalloprotease disintegrin ADAM8: processing by autocatalysis is required for proteolytic activity and cell adhesion*. J. Biol. Chem. 277(50), 48210\u201348219 (2002, Dec 13). https:\/\/doi.org\/10.1074\/jbc.M203355200","journal-title":"J. Biol. Chem."},{"issue":"1","key":"1266_CR12","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1038\/ncomms7175","volume":"6","author":"U. Schlomann","year":"2015","unstructured":"U. Schlomann, G. Koller, C. Conrad, T. Ferdous, P. Golfi, A.M. Garcia, S. H\u00f6fling, M. Parsons, P. Costa, R. Soper, M. Bossard, T. Hagemann, R. Roshani, N. Sewald, R.R. Ketchem, M.L. Moss, F.H. Rasmussen, M.A. Miller, D.A. Lauffenburger, D.A. Tuveson, C. Nimsky, J.W. Bartsch, ADAM8 as a drug target in pancreatic cancer. Nat. Commun. 6(1), 6175 (2015, Jan 28). https:\/\/doi.org\/10.1038\/ncomms7175","journal-title":"Nat Commun."},{"issue":"2","key":"1266_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13402-024-01001-0","volume":"48","author":"Y. Gao","year":"2025","unstructured":"Y. Gao, K. Zandieh, K. Zhao, N. Khizanishvili, P.D. Fazio, X. Yu, L. Schulte, M. Aillaud, H.-R. Chung, Z. Ball, M. Meixner, U.-M. Bauer, D.K. Bartsch, M. Buchholz, M. Lauth, C. Nimsky, L. Cook, J.W. Bartsch, The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8\/miR-181a-5p axis. Cell. Oncol. 48(2), 391\u2013409 (2025). https:\/\/doi.org\/10.1007\/s13402-024-01001-0","journal-title":"Cell. Oncol."},{"issue":"4","key":"1266_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1042\/BST20220162","volume":"50","author":"K.J. Murphy","year":"2022","unstructured":"K.J. Murphy, J. Zhu, M. Trpceski, B.A. Pereira, P. Timpson, D. Herrmann, Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy. Biochem. Soc. Trans. 50(4), 1129\u20131141 (2022, Aug 31). https:\/\/doi.org\/10.1042\/BST20220162","journal-title":"Biochem. Soc. Trans."},{"key":"1266_CR15","doi-asserted-by":"publisher","first-page":"154425","DOI":"10.1016\/j.prp.2023.154425","volume":"245","author":"H.R.A.K. Al-Hetty","year":"2023","unstructured":"H.R.A.K. Al-Hetty, S.J. Abdulameer, S.A. Alkubaisy, S.A. Zaid, A.T. Jalil, I.K. Jasim, STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target. Pathol. Res. Pract. 245, 154425 (2023, May 1). https:\/\/doi.org\/10.1016\/j.prp.2023.154425","journal-title":"Pathol - Res Pract"},{"issue":"2","key":"1266_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/jpm11020113","volume":"11","author":"C. Jaworek","year":"2021","unstructured":"C. Jaworek, Y. Verel-Yilmaz, S. Driesch, S. Ostgathe, L. Cook, S. Wagner, D.K. Bartsch, E.P. Slater, J.W. Bartsch, Cohort analysis of ADAM8 expression in the PDAC tumor stroma. JPM 11(2), 113 (2021, Feb 10). https:\/\/doi.org\/10.3390\/jpm11020113","journal-title":"JPM"},{"issue":"19","key":"1266_CR17","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.3390\/cancers14194910","volume":"14","author":"X. Liu","year":"2022","unstructured":"X. Liu, Y. Huang, Y. Qi, S. Wu, F. Hu, J. Wang, K. Shu, H. Zhang, J.W. Bartsch, C. Nimsky, F. Dong, T. Lei, The GBM tumor microenvironment as a modulator of therapy response: ADAM8 causes tumor infiltration of Tams through HB-EGF\/EGFR-Mediated CCL2 expression and overcomes TMZ chemosensitization in glioblastoma. Cancers 14(19), 4910 (2022, Oct 7). https:\/\/doi.org\/10.3390\/cancers14194910","journal-title":"Cancers"},{"issue":"1","key":"1266_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/dvdy.20221","volume":"232","author":"K. Kelly","year":"2005","unstructured":"K. Kelly, G. Hutchinson, D. Nebenius-Oosthuizen, A.J.H. Smith, J.W. Bartsch, K. Horiuchi, A. Rittger, K. Manova, A.J.P. Docherty, C.P. Blobel, Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice. Dev. Dyn. 232(1), 221\u2013231 (2005, Jan). https:\/\/doi.org\/10.1002\/dvdy.20221","journal-title":"Dev. Dyn."},{"issue":"14","key":"1266_CR19","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","volume":"71","author":"R.B. Corcoran","year":"2011","unstructured":"R.B. Corcoran, G. Contino, V. Deshpande, A. Tzatsos, C. Conrad, C.H. Benes, D.E. Levy, J. Settleman, J.A. Engelman, N. Bardeesy, STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res. 71(14), 5020\u20135029 (2011, Jul 15). https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0908","journal-title":"Cancer Res."},{"issue":"21","key":"1266_CR20","doi-asserted-by":"publisher","first-page":"31586","DOI":"10.18632\/oncotarget.8040","volume":"7","author":"R. Kanteti","year":"2016","unstructured":"R. Kanteti, S.K. Batra, F.E. Lennon, R. Salgia, FAK and paxillin, two potential targets in pancreatic cancer. Oncotarget 7(21), 31586\u201331601 (2016, May 24). https:\/\/doi.org\/10.18632\/oncotarget.8040","journal-title":"Oncotarget"},{"issue":"22","key":"1266_CR21","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41388-023-02701-x","volume":"42","author":"A.R. Poh","year":"2023","unstructured":"A.R. Poh, M. Ernst, Functional roles of SRC signaling in pancreatic cancer: recent insights provide novel therapeutic opportunities. Oncogene 42(22), 1786\u20131801 (2023, Jun). https:\/\/doi.org\/10.1038\/s41388-023-02701-x","journal-title":"Oncogene"},{"issue":"3","key":"1266_CR22","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3892\/etm.2016.2988","volume":"11","author":"X. Han","year":"2016","unstructured":"X. Han, Y. Wang, H. Chen, J. Zhang, C. Xu, J. Li, M. Li, Enhancement of ICAM-1 via the JAK2\/STAT3 signaling pathway in a rat model of severe acute pancreatitis-associated lung injury. Exp. Ther. Med. 11(3), 788\u2013796 (2016, Mar). https:\/\/doi.org\/10.3892\/etm.2016.2988","journal-title":"Exp Ther Med."},{"issue":"6","key":"1266_CR23","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/eji.201444960","volume":"45","author":"D.Y.S. Vogel","year":"2015","unstructured":"D.Y.S. Vogel, G. Kooij, P.D.A.M. Heijnen, M. Breur, L.A.N. Peferoen, P. van der Valk, H.E. de Vries, S. Amor, C.D. Dijkstra, GM-CSF promotes migration of human monocytes across the blood brain barrier. Eur. J. Immunol. 45(6), 1808\u20131819 (2015, Jun). https:\/\/doi.org\/10.1002\/eji.201444960","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"1266_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1183\/09031936.03.00303503","volume":"21","author":"M. Laan","year":"2003","unstructured":"M. Laan, O. Prause, M. Miyamoto, M. Sj\u00f6strand, A.M. Hyt\u00f6nen, T. Kaneko, J. L\u00f6tvall, A. Lind\u00e9n, A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-\u03b1. Eur. Respir. J. 21(3), 387\u2013393 (2003, Mar). https:\/\/doi.org\/10.1183\/09031936.03.00303503","journal-title":"Eur. Respir. J."},{"issue":"4","key":"1266_CR25","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/ijms23041976","volume":"23","author":"L. Cook","year":"2022","unstructured":"L. Cook, M. Sengelmann, B. Winkler, C. Nagl, S. Koch, U. Schlomann, E.P. Slater, M.A. Miller, E.P. von Strandmann, B. D\u00f6rsam, C. Preu\u00dfer, J.W. Bartsch, ADAM8-dependent extracellular signaling in the tumor microenvironment involves regulated release of Lipocalin 2 and MMP-9. IJMS 23(4), 1976 (2022, Feb 10). https:\/\/doi.org\/10.3390\/ijms23041976","journal-title":"IJMS"},{"issue":"15","key":"1266_CR26","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.3390\/ijms21155486","volume":"21","author":"N. Sperb","year":"2020","unstructured":"N. Sperb, M. Tsesmelis, T. Wirth, Crosstalk between tumor and stromal cells in pancreatic ductal adenocarcinoma. IJMS 21(15), 5486 (2020, Jul 31). https:\/\/doi.org\/10.3390\/ijms21155486","journal-title":"IJMS"},{"issue":"6","key":"1266_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"L.J. Bayne","year":"2012","unstructured":"L.J. Bayne, G.L. Beatty, N. Jhala, C.E. Clark, A.D. Rhim, B.Z. Stanger, R.H. Vonderheide, Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 21(6), 822\u2013835 (2012, Jun 12). https:\/\/doi.org\/10.1016\/j.ccr.2012.04.025","journal-title":"Cancer Cell."},{"issue":"6","key":"1266_CR28","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1158\/2159-8290.CD-22-1046","volume":"13","author":"A. Bianchi","year":"2023","unstructured":"A. Bianchi, I. De Castro Silva, N.U. Deshpande, S. Singh, S. Mehra, V.T. Garrido, X. Guo, L.A. Nivelo, D.S. Kolonias, S.J. Saigh, E. Wieder, C.I. Rafie, A.R. Dosch, Z. Zhou, O. Umland, H. Amirian, I.C. Ogobuiro, J. Zhang, Y. Ban, C. Shiau, N.S. Nagathihalli, E.A. Montgomery, W.L. Hwang, R. Brambilla, K. Komanduri, A.V. Villarino, E. Toska, B.Z. Stanger, D.I. Gabrilovich, N.B. Merchant, J. Datta, Cell-autonomous Cxcl1 sustains Tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discov. 13(6), 1428\u20131453 (2023, Jun 2). https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1046","journal-title":"Cancer Discov."},{"issue":"1","key":"1266_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s11658-024-00589-3","volume":"29","author":"Z. Qian","year":"2024","unstructured":"Z. Qian, R. Li, T. Zhao, K. Xie, P. Li, G. Li, N. Shen, J. Gong, X. Hong, L. Yang, H. Li, Blockade of the ADAM8-fra-1 complex attenuates neuroinflammation by suppressing the Map3k4\/MAPKs axis after spinal cord injury. Cell. Mol. Biol. Lett. 29(1), 75 (2024, May 16). https:\/\/doi.org\/10.1186\/s11658-024-00589-3","journal-title":"Cell. Mol. Biol. Lett."},{"key":"1266_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fimmu.2014.00489","volume":"5","author":"D. Laoui","year":"2014","unstructured":"D. Laoui, E. Van Overmeire, P. De Baetselier, J.A. Van Ginderachter, G. Raes, Functional relationship between tumor-associated Macrophages and macrophage colony-stimulating factor as contributors to cancer progression. Front Immunol 5, 489 (2014). https:\/\/doi.org\/10.3389\/fimmu.2014.00489","journal-title":"Front Immunol"},{"issue":"1","key":"1266_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1158\/2159-8290.CD-14-0474","volume":"5","author":"G.Y. Liou","year":"2015","unstructured":"G.Y. Liou, H. D\u00f6ppler, B. Necela, B. Edenfield, L. Zhang, D.W. Dawson, P. Storz, Mutant KRAS\u2013induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. Cancer Discov. 5(1), 52\u201363 (2015, Jan). https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0474","journal-title":"Cancer Discov."},{"issue":"4","key":"1266_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/antiox12040813","volume":"12","author":"M.J. Vera","year":"2023","unstructured":"M.J. Vera, F. Guajardo, F.A. Urra, N. Tobar, J. Mart\u00ednez, TNF-Alpha promotes an inflammatory mammary microenvironment that favors macrophage and epithelial migration in a CCL2- and mitochondrial-ROS-Dependent manner. Antioxid (Basel) 12(4), 813 (2023, Mar 27). https:\/\/doi.org\/10.3390\/antiox12040813","journal-title":"Antioxid (Basel)"},{"key":"1266_CR33","doi-asserted-by":"publisher","first-page":"901277","DOI":"10.3389\/fimmu.2022.901277","volume":"13","author":"A. Kumar","year":"2022","unstructured":"A. Kumar, A. Taghi Khani, A. Sanchez Ortiz, S. Swaminathan, GM-CSF: a double-edged sword in cancer immunotherapy. Front Immunol 13, 901277 (2022). https:\/\/doi.org\/10.3389\/fimmu.2022.901277","journal-title":"Front Immunol"},{"issue":"1","key":"1266_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1189\/jlb.0205067","volume":"78","author":"M.A. Lokuta","year":"2005","unstructured":"M.A. Lokuta, A. Huttenlocher, TNF-\u03b1 promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway. J. Leukoc. Biol. 78(1), 210\u2013219 (2005, Jul). https:\/\/doi.org\/10.1189\/jlb.0205067","journal-title":"J. Leukoc. Biol."},{"key":"1266_CR35","doi-asserted-by":"publisher","unstructured":"C. Conrad, D. Yildiz, S.J. Cleary, A. Margraf, L. Cook, U. Schlomann, B. Panaretou, J.L. Bowser, H. Karmouty-Quintana, J. Li, N.K. Berg, S.C. Martin, A. Aljohmani, S.F. Moussavi-Harami, K.M. Wang, J.J. Tian, M. Magnen, C. Valet, L. Qiu, J.P. Singer, H.K. Eltzschig, W. Bertrams, S. Herold, N. Suttorp, B. Schmeck, Z.T. Ball, A. Zarbock, M.R. Looney, J.W. Bartsch, ADAM8 signaling drives neutrophil migration and ARDS severity. JCI Insight [Internet]. 7(3). Available from: 2022, Feb 8). https:\/\/doi.org\/10.1172\/jci.insight.149870. https:\/\/insight.jci.org\/articles\/view\/149870. 2025 Aug 31","DOI":"10.1172\/jci.insight.149870"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01266-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01266-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01266-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:24:40Z","timestamp":1785763480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01266-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01266-7","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments (breeding, genotyping, cell isolations, tumor monitoring, and phenotyping) described here are according to the German Animal Welfare act (Tierschutzgesetz) implementing EU Directive 2010\/63\/EU and were authorized by the local authorities (Regierungspr\u00e4sidium Gie\u00dfen) under file name G_86\/2018 to JWB.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to publish this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"101"}}